findmyKOL
Clinical trialNCT00859937CompletedPhase 2Interventional

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

SponsorNational Cancer Institute (NCI)Enrollment55Malignant Salivary Gland NeoplasmRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic CarcinomaStage IV Major Salivary Gland Cancer AJCC v7
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • London Regional Cancer Program

    London, Ontario, Canada

  • University Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Chum-Hotel Dieu de Montreal

    Montreal, Quebec, Canada

United States
  • Tower Cancer Research Foundation

    Beverly Hills, California, United States

  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Mercy Uc Davis Cancer Center

    Merced, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Emory University Hospital/winship Cancer Institute

    Atlanta, Georgia, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Decatur Memorial Hospital

    Decatur, Illinois, United States

  • Northshore University Healthsystem-Evanston Hospital

    Evanston, Illinois, United States

  • Ingalls Memorial Hospital

    Harvey, Illinois, United States

  • Joliet Oncology-Hematology Associates Limited

    Joliet, Illinois, United States

  • Loyola University Medical Center

    Maywood, Illinois, United States

  • Illinois Cancercare-Peoria

    Peoria, Illinois, United States

  • Central Illinois Hematology Oncology Center

    Springfield, Illinois, United States

  • Fort Wayne Medical Oncology and Hematology Inc-Parkview

    Fort Wayne, Indiana, United States

  • Northern Indiana Cancer Research Consortium

    South Bend, Indiana, United States

  • University of Maryland/greenebaum Cancer Center

    Baltimore, Maryland, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

  • Oncology Care Associates Pllc

    Saint Joseph, Michigan, United States

  • Mercy Hospital Saint Louis

    St Louis, Missouri, United States

  • Mount Sinai Hospital

    New York, New York, United States

  • Montefiore Medical Center - Moses Campus

    The Bronx, New York, United States

  • Montefiore Medical Center-Wakefield Campus

    The Bronx, New York, United States

  • Unc Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Cancer Institute (upci)

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Vanderbilt University/ingram Cancer Center

    Nashville, Tennessee, United States

  • M D Anderson Cancer Center

    Houston, Texas, United States

  • Virginia Commonwealth University/massey Cancer Center

    Richmond, Virginia, United States

  • Froedtert and the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Mar 2009
Primary completion
30 Jan 2013
Completion
Last update posted
20 Apr 2018
Registered enrollment
55
Registry id
NCT00859937

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.